UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 157

Sortiert nach

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

Nature reviews. Cancer, 2013-02, Vol.13 (2), p.123

2013

Volltextzugriff (PDF)

Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma

Oncotarget, 2021-11, Vol.12 (24), p.2421-2433

2021

Volltextzugriff (PDF)

Role of miR-148a in hepatitis B associated hepatocellular carcinoma

PloS one, 2012-04, Vol.7 (4), p.e35331-e35331

2012

Volltextzugriff (PDF)

Editorial: Microbiome metabolites in health and disease

Frontiers in microbiology, 2023-09, Vol.14, p.1270001-1270001

2023

Volltextzugriff (PDF)

Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5344-5354

2013

Volltextzugriff (PDF)

The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease

Expert opinion on therapeutic targets, 2014-03, Vol.18 (3), p.293-306

2014

Volltextzugriff (PDF)

Does the Hepatitis B Antigen HBx Promote the Appearance of Liver Cancer Stem Cells?

Cancer research (Chicago, Ill.), 2011-05, Vol.71 (10), p.3701-3708

2011

Volltextzugriff (PDF)

Human Viral Oncogenesis: A Cancer Hallmarks Analysis

Cell host & microbe, 2014-03, Vol.15 (3), p.266-282

2014

Volltextzugriff (PDF)

Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B

Biomedicines, 2022-09, Vol.10 (9), p.2210

2022

Volltextzugriff (PDF)

Tupaia CD81, SR-BI, Claudin-1, and Occludin Support Hepatitis C Virus Infection

Journal of Virology, 2011-03, Vol.85 (6), p.2793-2802

2011

Volltextzugriff (PDF)

Short-chain fatty acids in cancer pathogenesis

Cancer and metastasis reviews, 2023-09, Vol.42 (3), p.677-698

2023

Volltextzugriff (PDF)

A spiroligomer α-helix mimic that binds HDM2, penetrates human cells and stabilizes HDM2 in cell culture

PloS one, 2012-10, Vol.7 (10), p.e45948

2012

Volltextzugriff (PDF)

COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma

World journal of gastroenterology : WJG, 2008-03, Vol.14 (9), p.1346-1352

2008

Volltextzugriff (PDF)

Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis

Cancer letters, 2007-07, Vol.252 (2), p.157-170

2007

Volltextzugriff (PDF)

Oxidative stress and antioxidants in hepatic pathogenesis

World journal of gastroenterology : WJG, 2010-12, Vol.16 (48), p.6035-6043

2010

Volltextzugriff (PDF)

Hepatitis C virus targets over‐expression of arginase I in hepatocarcinogenesis

International journal of cancer, 2009-06, Vol.124 (12), p.2886-2892

2009

Volltextzugriff (PDF)

Evaluation of Single and Combination Therapies with Tenofovir Disoproxil Fumarate and Emtricitabine In Vitro and in a Robust Mouse Model Supporting High Levels of Hepatitis B Virus Replication

Antimicrobial Agents and Chemotherapy, 2012-12, Vol.56 (12), p.6186-6191

2012

Volltextzugriff (PDF)

Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma

Cancer letters, 2006-07, Vol.239 (1), p.10-20

Feitelson, Mark A.

2006

Volltextzugriff (PDF)

Hedgehog Signaling Blockade Delays Hepatocarcinogenesis Induced by Hepatitis B Virus X Protein

Cancer research (Chicago, Ill.), 2012-11, Vol.72 (22), p.5912-5920

2012

Volltextzugriff (PDF)

TMEM43 promotes the development of hepatocellular carcinoma by activating VDAC1 through USP7 deubiquitination

Translational gastroenterology and hepatology, 2024, Vol.9, p.9-9

2024

Volltextzugriff (PDF)

Early molecular and genetic determinants of primary liver malignancy

Surgical Clinics of North America, 2004-04, Vol.84 (2), p.339-354

2004

Volltextzugriff (PDF)

Correction: UCN-01 induces S and G2/M cell cycle arrest through the p53/p21waf1 or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines

BMC cancer, 2014-04, Vol.14 (1), p.216-216

2014

Volltextzugriff (PDF)

Genetic mechanisms of hepatocarcinogenesis

Oncogene, 2002-04, Vol.21 (16), p.2593-2604

2002

Volltextzugriff (PDF)

Hepatitis Bx Antigen Stimulates Expression of a Novel Cellular Gene, URG4, that Promotes Hepatocellular Growth and Survival

Neoplasia (New York, N.Y.), 2002-07, Vol.4 (4), p.355-368

2002

Volltextzugriff (PDF)

1 – 25 von 157

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(134)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(103)
Life Sciences & Biomedicine
(90)
Humans
(83)
Animals
(56)
Hepatitis B Virus
(51)
Biological And Medical Sciences
(44)
Medical Sciences
(32)
Hepatocellular Carcinoma
(30)
Mice
(28)
Oncology
(27)
Liver Neoplasms - Virology
(26)
Carcinoma, Hepatocellular - Virology
(23)
Tumors
(21)
Liver Neoplasms - Genetics
(20)
Gastroenterology & Hepatology
(19)
Carcinoma, Hepatocellular - Genetics
(18)
Hepatitis B Virus - Genetics
(17)
Infectious Diseases
(17)
Viral Diseases
(17)
Viral Hepatitis
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

Sustained proliferation in cancer: Mechanisms and novel therapeutic targets

Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma

Role of miR-148a in hepatitis B associated hepatocellular carcinoma

Editorial: Microbiome metabolites in health and disease

Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly

The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease

Does the Hepatitis B Antigen HBx Promote the Appearance of Liver Cancer Stem Cells?

Human Viral Oncogenesis: A Cancer Hallmarks Analysis

Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B

Tupaia CD81, SR-BI, Claudin-1, and Occludin Support Hepatitis C Virus Infection

Short-chain fatty acids in cancer pathogenesis

A spiroligomer α-helix mimic that binds HDM2, penetrates human cells and stabilizes HDM2 in cell culture

COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma

Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis

Oxidative stress and antioxidants in hepatic pathogenesis

Hepatitis C virus targets over‐expression of arginase I in hepatocarcinogenesis

Evaluation of Single and Combination Therapies with Tenofovir Disoproxil Fumarate and Emtricitabine In Vitro and in a Robust Mouse Model Supporting High Levels of Hepatitis B Virus Replication

Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma

Hedgehog Signaling Blockade Delays Hepatocarcinogenesis Induced by Hepatitis B Virus X Protein

TMEM43 promotes the development of hepatocellular carcinoma by activating VDAC1 through USP7 deubiquitination

Early molecular and genetic determinants of primary liver malignancy

Correction: UCN-01 induces S and G2/M cell cycle arrest through the p53/p21waf1 or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines

Genetic mechanisms of hepatocarcinogenesis

Hepatitis Bx Antigen Stimulates Expression of a Novel Cellular Gene, URG4, that Promotes Hepatocellular Growth and Survival

Suchergebnisse filtern